Abstract
Background: Ischemic heart disease (IHD) have reached epidemic levels on global scale. Nearly 18 million deaths have been reported globally due to cardiovascular diseases. Ischemia Reversal Program (IRP) is a form of Ayurvedic therapy which combines use of panchkarma and allied therapy in the management of IHD. Aim and objectives: The present study was planned to study the effectiveness of IRP therapy in patients of myocardial ischemia attending Madhavbaug clinics in Pune, Maharashtra.
Materials and methods: This was a retrospective study conducted from May 2019 to October 2019, wherein we identified the data of patients suffering from IHD (positive for inducible ischemia from stress test) of either gender or any age, and who had attended the out-patient departments (OPDs) at Pune, Maharashtra, India. The data of patients who had been administered IRP with minimum 7 sittings over a span of 12 weeks were considered for the study.
Results: In the present study, medical records of 75 patients of IHD were analyzed. At the end of IRP therapy there was statistically significant reduction in weight as compared (64.10±10.54 kg) to baseline (69.52±12.18 kg) with a p-value of 0.01. Similar trend was observed in BMI, SBP, and DBP. VO2 peak was improved at the end of therapy i.e. 26.39±5.55 mL/kg/min as
compared to baseline i.e. 15.72±5.03 mL/kg/min (p<0.001). DTS improved from -2.99±5.81 at baseline to 3.29±6.33 at week 12 of IRP therapy (p<0.0001). Conclusion: Findings of present study suggest that the application of the IRP can delay the onset of ischemia and result in an improvement in the overall quality of life.
Locate a Centre
